$CERS

Entry price: 6.99

Fundamentals:

- Sector: Medical - Biotech

- EPS % Chg (Last Qtr): 38%

- EPS % Chg (Previous Qtr): 31%

- 3 Year EPS Growth Rate: 0%

- EPS Est % Chg (Current Yr): 0%

- Sales % Chg (Last Qtr): 31%

- Sales % Chg (Previous Qtr): 18%

- 3-Year Sales Growth Rate: 27%

- Annual Pre -Tax Margin: -75.7%

Kommentar:

Added
Average price: 7.10

Kommentar:

________________________
- EPS % Chg (Last Qtr): 25%
- Sales % Chg (Last Qtr): 27%

Kommentar:

Sold at 6.30
Return: -11.32%

Kommentar: